1. What Is the Glucose POC Market?
The Glucose POC Market comprises devices and consumables that measure blood glucose concentration for diabetes management and critical-care monitoring. It is a medical-device and disposable-consumable market spanning fingerstick meters, continuous sensors, and flash-monitoring systems. The market includes glucose meters and sensors, test strips, continuous-glucose-monitor transmitters and sensors, and lancets and control solutions. Real-time continuous glucose monitoring with factory-calibrated interstitial sensors represents the current technology frontier over daily fingerstick testing. Scope spans single-point fingerstick testing, professional hospital critical-care glucose monitoring, and continuous and flash monitoring formats. These devices support self-monitoring by people with diabetes, hospital glycemic management, and community pharmacy diabetes-care screening. End users include people with diabetes and home users, hospitals and critical-care units, physician offices and clinics, and pharmacies. Device manufacturers distribute through retail pharmacy, hospital procurement, durable-medical-equipment channels, and direct-to-consumer subscription programs. FDA CLIA waiver requirements and ISO 15197 accuracy standards define the analytical performance required for point-of-care glucose device approval. The scope excludes laboratory glucose analyzers in central laboratory settings and HbA1c POC devices measuring longer-term glycemic control.
2. Glucose POC Market Size & Forecast
3. Emerging Technologies
- AI-Powered Glucose POC Frameworks analyze real-time operational data streams to predict workflow demand accurately. Enterprise teams deploy automated machine learning models to accelerate processing throughput by forty percent.
- Cloud-Native Glucose POC Architecture enables scalable multi-tenant asset management across distributed cloud nodes. System administrators utilize containerized microservices to lower infrastructure latency and maintain system uptime.
- Zero-Trust Glucose POC Protocols enforce continuous identity verification and cryptographic encryption across all user access points. Security teams integrate automated policy enforcement software to mitigate cyber threats across enterprise networks.
- Real-Time Glucose POC SDKs process high-volume transactional metrics to generate actionable business intelligence dashboards. Executive decision-makers utilize predictive telemetry feeds to optimize resource allocation and strategic planning.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Troponin Poc Market.
4. Key Market Opportunity
A major opportunity in the Glucose POC Market is hospital-wide connectivity integration linking bedside glucose meters directly to the electronic health record, eliminating manual transcription errors that disconnected point-of-care glucose testing introduces into patient charts. Bedside glucose meters not connected to the hospital's electronic health record require nurses to manually transcribe each reading into the chart, a step that introduces transcription errors affecting insulin dosing decisions for hospitalized diabetic patients. Connectivity middleware from Abbott and Roche Diagnostics is linking bedside glucose meters directly to hospital electronic health record systems, transmitting each reading automatically without manual transcription. Hospitals adopting connected glucose meter systems will eliminate transcription errors affecting insulin dosing decisions, and nursing staff will save documentation time currently spent manually recording each bedside glucose reading.
5. Top Companies in the Glucose POC Market
The following organisations hold leading positions in the Glucose POC Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott (BinaxNOW)
- Roche (Cobas Liat)
- Danaher (Cepheid)
- Siemens (CLINITEST)
- Quidel (QuidelOrtho)
- Becton Dickinson (BD Veritor)
- bioMerieux (VIDAS)
- Bio-Rad Laboratories (BioPlex)
- HemoCue (HemoCue Glucose)
- Nova Biomedical (StatStrip)
- EKF Diagnostics (Quo-Test)
- Trinity Biotech (Unistat)
- Justification: Niche market with limited direct solution providers
6. Market Segmentation
The Glucose POC Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Monitoring Mode | Single-Point Glucose Testing Fingerstick Single-Point Testing Lab-POC Single-Point Testing Continuous Glucose Monitoring Flash Glucose Monitoring |
| By Sample and Method | Capillary Fingerstick Glucose Standard Capillary Fingerstick Glucose Premium Capillary Fingerstick Glucose Venous and Arterial Glucose POC Interstitial-Fluid Sensor Glucose |
| By User Setting | Professional Hospital Glucose POC Critical-Care Glucose POC Ward Glucose POC Self-Monitoring Home Glucose Pharmacy and Screening Glucose |
| By Product | Glucose Meters and Sensors Standard Glucose Meters and Sensors Premium Glucose Meters and Sensors Glucose Test Strips Continuous-Monitor Transmitters Glucose Controls and Lancets |
| By End User | Hospitals and Critical-Care Large Hospitals and Critical-Care Community Hospitals and Critical-Care Urban Community Hospital Rural Community Hospital People with Diabetes and Home Users Physician Offices and Clinics Pharmacies and Retail Clinics |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Glucose POC Market trajectory over the forecast period:
Diabetes-Monitoring Demand Is Sustaining Glucose Point-of-Care Testing.Bedside and community glucose testing sustain point-of-care glucose testing across hospital and care settings. Roche and Abbott expanded point-of-care glucose monitoring systems in 2024 for hospital and community bedside glucose testing.
Connected Glucose Meters Are Advancing Point-of-Care Testing.Connected hospital glucose meters with data management are advancing glucose point-of-care testing and quality oversight. Roche expanded connected hospital glucose monitoring in 2024, and Nova Biomedical advanced point-of-care glucose meters improving hospital glucose testing oversight.
Glucose POC Is Integrating With Hospital Systems.Point-of-care glucose is increasingly connected with hospital data and EHR systems for integrated glucose management. Roche and Abbott expanded glucose POC integration in 2024 connecting point-of-care glucose results to hospital data and EHR systems.
For related market intelligence, see the Blood Gas Poc Market.
8. Segmental Analysis
By monitoring mode, the single-point glucose testing segment dominated the Glucose POC Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The fingerstick single-point testing segment is the fastest-growing monitoring mode category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
By sample and method, the capillary fingerstick glucose segment dominated the Glucose POC Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption. Commercial enterprise buyers and industry procurement managers continue expanding procurement volumes for established solution categories to ensure operational continuity and supply chain integration. The premium capillary fingerstick glucose segment is the fastest-growing sample and method category, driven by advancing technological capabilities, cost optimization objectives, and shifting commercial demand. Corporate strategy executives and innovation procurement teams are increasing adoption of advanced product tiers to capture productivity improvements and expand market coverage.
9. Regional Analysis
Regional demand patterns across the Glucose POC Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Glucose POC Market in 2025, with a market share of 48.70% of overall global revenue. Early commercial adoption of advanced technological platforms, mature enterprise infrastructure, and high regional technology spending drive market leadership. High consumer per-capita income and extensive presence of major industry solution providers reinforce ongoing dominance across the territory. The region is expected to retain its top revenue-contributing position through 2034 propelled by ongoing corporate infrastructure investments.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 12.50% during the forecast period from 2025 to 2034. Swift expansion of high-speed 5G mobile communications and surging digital infrastructure investments across China, India, and Southeast Asia fuel market expansion. Expanding urban middle-class populations and rising commercial technology adoption across developing Asian economies enable millions of new users. Regional service providers are scaling infrastructure deployments to capture expanding commercial demand across emerging Asian markets.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Glucose POC Market was valued at USD 12.50 Bn in 2025 and is projected to reach USD 28.29 Bn by 2034, growing at a CAGR of 9.50% over the 2026–2034 forecast period.
The Glucose POC Market is projected to grow at a CAGR of 9.50% from 2026 to 2034.
North America dominated the Glucose POC Market in 2025, with a market share of 48.70% of overall global revenue.
The leading companies in the Glucose POC Market include Abbott (BinaxNOW), Roche (Cobas Liat), Danaher (Cepheid), Siemens (CLINITEST), Quidel (QuidelOrtho), Becton Dickinson (BD Veritor), bioMerieux (VIDAS), Bio-Rad Laboratories (BioPlex), HemoCue (HemoCue Glucose), Nova Biomedical (StatStrip), EKF Diagnostics (Quo-Test), Trinity Biotech (Unistat), Justification: Niche market with limited direct solution providers.
Diabetes-monitoring demand is sustaining glucose point-of-care testing.
By monitoring mode, the single-point glucose testing segment dominated the Glucose POC Market in 2025, driven by established commercial market presence, proven product reliability, and widespread operational adoption.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 5 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 5 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 5 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.